MK
Manan Kalpesh Kinariwala
About Manan Kalpesh Kinariwala
Data last updated:
Manan Kalpesh Kinariwala has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Kingenic Lifescience Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Kingenic Lifescience Private Limited at ₹53.4 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kingenic Lifescience Private Limited U24100GJ2019PTC109306 | Director | 18 Feb 2020 | 2019 | ₹53.4 Lakh (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Manan Kalpesh Kinariwala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Manan Kalpesh Kinariwala
Manan Kalpesh Kinariwala has 6 years in corporate governance. Holds Director role. Currently with 1 company, including Kingenic Lifescience Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Kingenic Lifescience Private Limited at ₹53.4 Lakh (FY 2024).
Manan Kalpesh Kinariwala is associated with 1 company as Director, including Kingenic Lifescience Private Limited (₹53.4 Lakh).
Manan Kalpesh Kinariwala has expertise in General Business.
Manan Kalpesh Kinariwala has 6 years in corporate governance.
By reported revenue, the largest current company of Manan Kalpesh Kinariwala is Kingenic Lifescience Private Limited, with revenue of ₹53.4 Lakh (FY 2024).
Manan Kalpesh Kinariwala currently holds positions at 1 company: Kingenic Lifescience Private Limited (₹53.4 Lakh).